Merck & Co. Inc. buy Wells Fargo & Company
Start price
24.11.25
/
50%
€87.10
Target price
24.11.26
€108.59
Performance (%)
20.32%
Price
27.02.26
€104.80
Summary
This prediction is currently active. The prediction currently has a performance of 20.32%. This prediction currently runs until 24.11.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 0.963% | 0.963% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $125.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€100.00
04.02.26
04.02.26
€114.17
04.02.27
04.02.27
4.80%
27.02.26
27.02.26
